Pandemic-related changes in alcohol use among LGB+ people with and without mental health and neurodevelopmental conditions: a multinational cross-sectional study
Drugs, Habits and Social Policy
ISSN: 2752-6739
Article publication date: 11 December 2023
Issue publication date: 14 May 2024
Abstract
Purpose
Using data from 36,981 respondents to the Global Drug Survey (GDS) COVID-19 Special Edition, this study aims to compare changes, following the first “lockdown,” in alcohol consumption between lesbian, gay, bisexual and other sexual minority (LGB+) and heterosexual respondents with and without lifetime mental health and neurodevelopmental (MHND) conditions.
Design/methodology/approach
Characteristics and drinking behavior of respondents to GDS who disclosed their sexual orientation and past 30-day alcohol use were described and compared. LGB+ participants with and without MHND conditions were compared, and logistic regression models identified correlates of increased drinking among LGB+ people. The impact of changed drinking on the lives of LGB+ participants with and without MHND conditions was assessed.
Findings
LGB+ participants who reported that they were “not coping well at all” with the pandemic had twofold greater odds of reporting increased binge drinking. LGB+ participants with MHND conditions were significantly more likely than those without to report increased drinking frequency (18.7% vs 12.4%), quantity (13.8% vs 8.8%) and that changed drinking had impacted their lives.
Originality/value
This study, which has a uniquely large and international sample, explores aspects of alcohol use not considered in other COVID-19 alcohol use research with LGB+ people; and to the best of the authors’ knowledge, this is the first study to explore alcohol use among LGB+ people with MHND conditions.
Keywords
Acknowledgements
The authors express our gratitude to the media and harm reduction organisations that support Global Drug Survey. Authors also appreciate the time that participants have generously volunteered to complete the survey.
Funding: This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.
Data availability statement: Global Drug Survey is an independent research company. As such, supporting data are not available.
Disclosure of interest: Adam Winstock is the CEO of Global Drug Survey. The remaining authors report no conflict of interest.
Citation
Connolly, D.J., Gilchrist, G., Ferris, J., Puljević, C., Maier, L., Barratt, M.J., Winstock, A. and Davies, E.L. (2024), "Pandemic-related changes in alcohol use among LGB+ people with and without mental health and neurodevelopmental conditions: a multinational cross-sectional study", Drugs, Habits and Social Policy, Vol. 25 No. 1, pp. 97-109. https://doi.org/10.1108/DHS-08-2023-0032
Publisher
:Emerald Publishing Limited
Copyright © 2023, Emerald Publishing Limited